Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ángel J De la Rosa"'
Autor:
Raúl González, Ángel J De la Rosa, Alessandro Rufini, María A Rodríguez-Hernández, Elena Navarro-Villarán, Trinidad Marchal, Sheila Pereira, Manuel De la Mata, Martina Müller-Schilling, Juan M Pascasio-Acevedo, María T Ferrer-Ríos, Miguel A Gómez-Bravo, Francisco J Padillo, Jordi Muntané
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174326 (2017)
Patients with hepatocellular carcinoma (HCC) submitted to orthotopic liver transplantation (OLT) have a variable 5-year survival rate limited mostly by tumor recurrence. The etiology, age, sex, alcohol, Child-Pugh, and the immunesuppressor have been
Externí odkaz:
https://doaj.org/article/d9fc9daee3de433db4438a5f49e88f07
Autor:
Raúl González, Ángel J. De la Rosa, Santiago Romero-Brufau, Lydia Barrera-Pulido, Francisco Gallardo-Chamizo, Sheila Pereira, Luís M. Marín, José M. Álamo, Ángeles Rodríguez-Hernández, Francisco J. Padillo, Jordi Muntané
Publikováno v:
Redox Biology, Vol 5, Iss , Pp 420-421 (2015)
Hepatocellular carcinoma develops in cirrhotic liver. The nitric oxide (NO) synthase type III (NOS-3) overexpression induces cell death in hepatoma cells. The study developed gene therapy designed to specifically overexpress NOS-3 in cultured hepatom
Externí odkaz:
https://doaj.org/article/2fe6f4a4c1a04f53ab578391f1b02a7a
Autor:
José L. Quiles, Ángel J. De la Rosa, José L. Mauriz, Francisco J. Padillo, Raúl González, José M. Fuentes, Jesús de la Cruz, Javier González-Gallego, Elena Navarro-Villarán, Raquel Ordóñez, L.M. Marín-Gómez, Jordi Muntané, Mario Rodríguez-Arribas, María A. Rodríguez-Hernández, J.M. Álamo-Martínez, Paloma Gallego, Laura Contreras, José A Del Campo
Publikováno v:
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
instname
Sorafenib is the unique accepted molecular targeted drug for the treatment of patients in advanced stage of hepatocellular carcinoma. The current study evaluated cell signaling regulation of endoplasmic reticulum (ER) stress, c-Jun-N-terminal kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13faddb9a0c020090635a3ed453ddd5e
https://hdl.handle.net/10668/12863
https://hdl.handle.net/10668/12863
Autor:
Francisco J. Padillo, O Sobotka, Zuzana Červinková, Raúl González, Ángel J. De la Rosa, J.M. Álamo-Martínez, Pavla Staňková, Jordi Muntané, L.M. Marín-Gómez, Otto Kucera, A. Rodríguez-Hernández
Publikováno v:
Free Radical Biology and Medicine. 120:S107
Sorafenib is the accepted molecular therapy for advanced hepatocarcinoma. Sorafenib reduced mitochondrial oxygen consumption, polarization and superoxide anion production in HepG2. These effects paralleled the induction of endoplasmic reticulum stres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::068e0c2fb9b1cbe7193ba3f3b21b54ff
https://doi.org/10.1016/j.freeradbiomed.2018.04.353
https://doi.org/10.1016/j.freeradbiomed.2018.04.353
Autor:
J.M. Pascasio-Acevedo, María A. Rodríguez-Hernández, Sheila Pereira, Jordi Muntané, Miguel Ángel Gómez-Bravo, Elena Navarro-Villarán, Raúl González, Alessandro Rufini, Martina Müller-Schilling, Manuel de la Mata, Trinidad Marchal, Francisco J. Padillo, Ángel J. De la Rosa, M.T. Ferrer-Ríos
Publikováno v:
PLoS ONE
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 12, Iss 3, p e0174326 (2017)
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 12, Iss 3, p e0174326 (2017)
[Background & Aims] Patients with hepatocellular carcinoma (HCC) submitted to orthotopic liver transplantation (OLT) have a variable 5-year survival rate limited mostly by tumor recurrence. The etiology, age, sex, alcohol, Child-Pugh, and the immunes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97249ce84e12d3ee7190d17fe9cb1a7
https://doi.org/10.1371/journal.pone.0174326
https://doi.org/10.1371/journal.pone.0174326